These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7684615)

  • 1. Generation and partial characterization of five monoclonal antibodies with high affinities for fibrin.
    Tymkewycz PM; Creighton Kempsford LJ; Gaffney PJ
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):211-21. PubMed ID: 7684615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S; Gaffney PJ
    Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for fibrin specific monoclonal antibodies: the development of a new procedure.
    Tymkewycz PM; Creighton-Kempsford LJ; Hockley D; Gaffney PJ
    Thromb Haemost; 1992 Jul; 68(1):48-53. PubMed ID: 1514172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F; Haber E; Matsueda GR
    Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of monoclonal antibodies for research on fibrin polymerization processes].
    Lugovskoĭ EV; Makogonenko EM; Chudnovets VS; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Liashko ED; Komissarenko SV
    Dokl Akad Nauk SSSR; 1991; 318(1):224-7. PubMed ID: 1716547
    [No Abstract]   [Full Text] [Related]  

  • 7. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The (DD)E complex is maintained by a composite fibrin polymerization site.
    Moskowitz KA; Budzynski AZ
    Biochemistry; 1994 Nov; 33(44):12937-44. PubMed ID: 7524657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neoantigenic determinant in coiled coil region of human fibrin beta-chain.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Lugovskaya NE; Komisarenko SV
    Thromb Res; 2009 Mar; 123(5):765-70. PubMed ID: 18977516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo penetration of experimentally produced clots by monoclonal antibodies.
    McEvoy FJ; Edgell TA; Webbon PM; Gaffney PJ
    Thromb Haemost; 2000 Jun; 83(6):882-6. PubMed ID: 10896242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1984 Jan; 21(1):89-94. PubMed ID: 6200769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase.
    Charpie JR; Runge MS; Matsueda GR; Haber E
    Biochemistry; 1990 Jul; 29(27):6374-8. PubMed ID: 1698452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility of epitopes on fibrin clots and fibrinogen gels.
    Procyk R; Kudryk B; Callender S; Blombäck B
    Blood; 1991 Apr; 77(7):1469-75. PubMed ID: 1706954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
    Hui KY; Haber E; Matsueda GR
    Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies.
    Osaki T; Magari Y; Souri M; Ichinose A
    Monoclon Antib Immunodiagn Immunother; 2024 Oct; 43(5):135-143. PubMed ID: 39320988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.